Publikationen

Yvette Meissner, Frauke Foerger et al.: European Network of Pregnancy Registers in Rheumatology (EuNeP)—an overview of procedures and data collection. Arthritis Research & Therapy, November 2019

Burkhard Möller, Michael Andor et al.: Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years. Rheumatology (Oxford). 2019 Oct 19. pii: kez460. doi: 10.1093/rheumatology/kez460

Lykke Midtbøll Ørnbjerg, Adrian Ciurea et al.: Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. ARD Journals, Oktober 2019

Pascal Zufferey, Delphine S.Courvoisier et al.: Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life. Joint Bone Spine, September 2019

Janick Rohrbach, Tobias Reinhard et al.: Bone erosion scoring for rheumatoid arthritis with deep convolutional neural networks. Computers & Electrical Engineering, August 2019, August 2019

Anne Boel, Adrian Ciurea et al.: Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. BMJ Journals, July 2019

Kim Lauper, Denis Mongin, Deshire Alpizar-Rodriguez et al.: Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution. Rheumatology, June 2019

Monika Hebeisen, Adrian Ciurea et al.: Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLOS|ONE, May 2019

Godehard A. Scholz, Alexander B. Leichtle, Burkhard Möller et al.: The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. British Journal of Haematology, April 2019

Alpizar-Rodriguez, A., Förger F. et al.: Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort. Rheumatology, Oct 2018

Lauper K., Mongin D., Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries. RMD Open, Sept. 2018

Oude Voshaar M. A. H., Dourvoisier D., van de Laar M.A.F.J. et al: Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric. Quality of Life Research, September 2018

Lechtenböhmer C.A., Hügle T. et al: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of concomitant Interphalangeal Joint Osteoarthritis. Arthritis and Rheumatology, August 2018

Didden E.M., Egger M., Finckh A. et al: Prediction of Real-World Drug Effectiveness Pre-Launch: Case Study in Rheumatoid Arthritis. Medical Decision Making, August 2018

Martinez-Prat L., Nissen M.J. et al: Comparison of serological Biomarkers in rheumatoid arthritis and their combination to improve Diagnostic Performance. Frontiers in Immunology, June 2018

Lauper K., Gabay C., et al: Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic DMARDs in patients with rheumatoid arthritis after the use of at least one biologic DMARD: analyses from the pan-European TOCERRA register collaboration. Ann Rheum Dis. May 2018; 0:1-7, doi: 10.1136/annrheumdis-2017-212845

Müller, R.B., von Kempis, J. et al: Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort. Rheumatic and muscosceletal diseases (RMD) open, May 2018

Hebeisen, M., Ciurea A., et al.: Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort. J Rheumatol. 2018 Apr;45(4):506-512. doi: 10.3899/jrheum.170166

Lauper K., Gabay C., et al: Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. Arthritis Care Res. Apr. 2018, doi: 10.1002/acr.23567

Heinimann, K., von Kempis, J., et al.: Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort. J Clin Med. 2018 Mar 13;7(3). pii: E57. doi: 10.3390/jcm7030057